Seoul Semiconductor: SunLike Series Natural Spectrum LEDs Illuminate Pompeii Ruins
Seoul Semiconductor, a global innovator of LED products and technology, announces that its SunLike Series natural spectrum LEDs have been adopted for a lighting project to illuminate the restored murals of the Casa dei Vettii in the ruins of the ancient city of Pompeii, Italy. The lighting project was undertaken by the Lumen Center Italia’s “luum” technical lighting division, which specified the SunLike Series natural spectrum LEDs because they produce light that closely matches the spectrum of natural sunlight, which conveys the colors and textures of the restored murals accurately as they would naturally appear.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180307005555/en/
Casa dei Vettii murals in Pompeii illuminated by conventional LEDs (left) and SunLike Series natural spectrum LEDs (right) (Photo: Business Wire)
Augusto Grillo, the president of Lumen Center Italia (LCI), the premium lighting company in Italy promoting the Pompeii heritage lighting project, explained, ”Because SunLike has a level of blue light similar to that of sunlight and a superior Color Index Rendering (CRI) and Color Quality Scale (CQS), we believe it is ideal for artwork and museum lighting. We are delighted with the amazing technology of SunLike LEDS and hope to adopt SunLike for more projects in the future.”
Caleb Won, the executive vice president of global marketing at Seoul Semiconductor, said “We are pleased to have our SunLike Series LED technology chosen to illuminate the murals of Pompeii, a world heritage site. This is just the latest example of the success of the SunLike Series LEDs."
The Lumen Center Italia (LCI) has developed spotlights that employ nine units of 25W COB-type SunLike Series natural spectrum LEDs from Seoul Semiconductor to illuminate the restored murals in the Pompeii ruins in Casa dei Vettii, Italy. The SunLike Series LEDs reproduce the spectrum of sunlight as closely as possible to show the color of the object as it appears in natural light and provide a good sense of depth based on high contrast ratio to accurately represent the murals.
Most artificial lights, such as fluorescent lights and conventional LEDs, exhibit light with a different spectrum from natural sunlight. The light output of those devices typically has a higher peak of blue light when compared to sunlight. Even conventional LEDs with a high CRI (Color Rendering Index) of 90, have a significantly lower color quality than natural sunlight. The oversaturation of blue light produces a scattering effect, causing distortion in the color of objects and making it difficult to accurately identify their contrasts.
SunLike LED technology, on the other hand, produces light with superior color quality compared with conventional LEDs because the spectrum of SunLike LEDs closely matches that of natural sunlight. Conventional artificial lighting has applied the color rendering index (CRI) that evaluates color quality based on fluorescent lamps. However, as LED technology has advanced, it has exceeded the color quality of fluorescent lamps. As a result, new standards of color quality scales are being used. In particular, if the existing CRI (color rendering) was the mechanical color used for experiments and measurements, CQS is characterized by the expression of more natural colors that the human eye can perceive.
In case of conventional LEDs, color rendering is high, but CQS is low. However, light produced by SunLike LEDs can achieve the best color quality in both color standards, such as color rendering and CQS because it has a 95%+ rating for both CRI and CQS. This is the same principle as expressing color by using the seven rainbow colors of red, orange, yellow, green, blue, indigo, and violet, and further segmenting and quantifying color.
SunLike Series LEDs combine Seoul Semiconductor's optical semiconductor technology with Toshiba Materials' natural light spectrum technology, TRI-R technology, limits the level of blue light to that of sunlight and minimizes the light scattering phenomenon. So, premium lighting companies around the world, which need to implement the closest spectrum to sunlight with high quality, have expressed continuing interest in the SunLike LED technology.
About TRI-R technology
TRI-R is a registered trademark of Toshiba Material Co., Ltd. It is a natural light LED light source technology that reproduces the spectrum of natural sunlight, developed by the concept and spectrum technology of natural light.
About Lumen Center Italia:
Since 1976 Lumen Center Italia (LCI) is an advanced laboratory of research, design and production of lighting fixtures. Through the latest research projects by their technical lighting division "luum", they offers the best selection of LED light sources attentive to the interaction between human metabolism and light, with a very high color rendering and a light source spectrum comparable to daylight.
Lumen Center Italia by its "luum" division has illuminated art works master pieces in the Vatican Museums, Pinacoteca Ambrosiana and others, including: Leonardo da Vinci’s Codex Atlanticus, the paintings of Botticelli, Tiziano, Bruegel and many more.
About Seoul Semiconductor:
Seoul Semiconductor develops and commercializes light emitting diodes (LEDs) for automotive, general illumination, specialty lighting, and backlighting markets. As the fourth-largest LED manufacturer globally, Seoul Semiconductor holds more than 12,000 patents, offers a wide range of technologies, and mass produces innovative LED products such as SunLike – delivering the world’s best light quality in a next-generation LED enabling human-centric lighting optimized for circadian rhythms; WICOP – a simpler structured package-free LED which provides market leading color uniformity, cost savings at the fixture level with high lumen density and allows design flexibility; NanoDriver Series – the world’s smallest 24W DC LED Drivers; Acrich, the world's first high-voltage AC-driven LED technology developed in 2005, includes all AC LED-related technologies from chip to module and circuit fabrication, as well as multi-junction technology (MJT); and nPola, a new LED product based on GaN-substrate technology that achieves more than ten times the output of conventional LEDs. UCD constitutes a high color gamut display which delivers more than 90% NTSC.
For more information about Seoul Semiconductor, please visit http://www.seoulsemicon.com
Wicop and Acrich are trademarks of Seoul Semiconductor Co., Ltd.
Seoul Semiconductor Europe GmbH
Seoul Semiconductor Inc.
Seoul Semiconductor Co., Ltd
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Takeda Receives Positive CHMP Opinion Recommending ALUNBRIG® (brigatinib) for the Treatment of ALK+ Non-Small Cell Lung Cancer in Patients Previously Treated with Crizotinib21.9.2018 13:30 | Pressemelding
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending the full approval of ALUNBRIG® (brigatinib) as a monotherapy for the treatment of adult patients with anaplastic lymphoma kinase-positive (ALK+) advanced non-small cell lung cancer (NSCLC) previously treated with crizotinib. ALUNBRIG is a tyrosine kinase inhibitor (TKI) designed to target and inhibit the ALK mutation in NSCLC. Approximately three to five percent of NSCLC patients globally have the ALK mutation. If the CHMP opinion is affirmed, and the European Commission approves ALUNBRIG, it will become the only ALK inhibitor available in the European Union as a one tablet per day dose that can be taken with or without food. The randomized, global Phase 2 ALTA trial was designed to investigate the efficacy and safety of ALUNBRIG in patients with locally advanced or metastatic ALK+
Asda Selects HCL Technologies to Help Drive IT Transformation21.9.2018 12:16 | Pressemelding
HCL Technologies (HCL), a leading global technology company, today announced that it has been selected to help drive IT transformation at the UK’s third-largest grocery retailer, Asda. The three-year application services contract will see HCL transform Asda’s IT Application Services with a new DevOps delivery model to drive data and analytics and support back-office applications through the full lifecycle of development, testing and support. HCL will also build a central data management platform to enable Asda to improve its insight and analytics capabilities. Asda operates more than 600 stores across the UK, employing over 135,000 people. Asda wanted to adopt a more agile approach towards application development and testing. This would allow the company to respond faster to business requirements and reduce time to market, while driving better user experience and satisfaction. HCL was selected due to its extensive expertise in successfully delivering similar large scale IT transformati
Ipsen Receives Positive CHMP Opinion for Cabometyx® (Cabozantinib) for the Second-line Treatment of Patients with Hepatocellular Carcinoma (HCC)21.9.2018 05:30 | Pressemelding
Regulatory News: Ipsen (Euronext:IPN; ADR:IPSEY) announced today that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), provided a positive opinion for Cabometyx® (cabozantinib) as a monotherapy for the treatment of hepatocellular carcinoma (HCC) in adults who have been previously treated with sorafenib. The CHMP positive opinion will now be reviewed by the European Commission (EC), which has the authority to approve medicines for the European Union (EU). Alexandre Lebeaut, MD, Executive Vice President, R&D and Chief Scientific Officer, Ipsen, said: “The global burden of liver cancer is increasing and despite the recent introduction of new agents, it remains the second leading cause of cancer mortality worldwide. Following today’s positive CHMP opinion and if approved by the European Commission, Cabometyx ® as monotherapy will give patients with HCC a much-needed new oral therapeutic option.” Dr Lorenza Rimassa,
Quanergy Selected as Exclusive LiDAR Partner for VRCO21.9.2018 05:00 | Pressemelding
Quanergy Systems, Inc., a global leader in the design and development of solid state LiDAR sensors and smart sensing solutions, and VRCO, designer and manufacturer of the luxury high-end e-VTOL (electric Vertical Take-Off and Landing) craft, the NeoXcraft XP2, today announced that VRCO will exclusively use Quanergy’s S3 solid state LiDAR sensors in the testing and market release versions of the aircraft. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180920006036/en/ VRCO NeoXcraft XP2 with Quanergy S3 LiDAR Sensor (Graphic: Business Wire) The NeoXcraft XP2, which VRCO and the University of Derby unveiled in late 2017 and intend to launch in 2020, is a two-passenger e-VTOL high-speed land, air, and water capable craft. The craft can scan and memorize take-off locations and store the data for use on the next approach to the same location. Quanergy’s innovative S3 solid state LiDAR sensor will be used for downward and forward
Overseas Roadshow for the IAPH Guangzhou 2019 World Ports Conference Was Held in London21.9.2018 03:08 | Pressemelding
Overseas roadshow for the IAPH Guangzhou 2019 World Ports Conference was successfully held in Armourer's Hall, London, UK on September 20th. Ms. Yuan Yue, Deputy Director General of Guangzhou Port Authority, met with over 100 senior representatives from British ports, ship-owners, commodity traders, shipping & service companies, shipping public policy research institutes, and other representatives from the port and shipping industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180920006031/en/ Speech made by Lord Jeffrey Evans, Chairman of Maritime London (Photo: Business Wire) In her keynote speech, Ms. Yuan Yue said, “Guangzhou is the gateway city of South China and is known as the “Millennium Business Capital” and a popular destination for business and investment. At present, Guangzhou has attracted investors from over 130 countries. Nearly 300 of the world's top 500 companies have businesses and investment in Guangzho
AbuDhabi Dubai STOB Series 22 Investment Enters into Favorable Tender Offer Agreement with MINDOL HOLDINGS21.9.2018 01:00 | Pressemelding
AbuDhabi Dubai STOB Series 22 Investment Limited Partnership, hereafter AbuDhabi22, and MINDOL HOLDINGS LIMITED, hereafter MINDOL, listed on the Hong Kong-based Coinsuper exchange (https://www.coinsuper.com) have reached an agreement where AbuDhabi22 will acquire the minimum 33.3 percent holding for the MINDOL cryptocurrency (MIN, https://mindol.net) to be issued by MINDOL, via a tender offer (TOB). Implementation of the TOB will serve to strengthen the strategic partnership with MINDOL. Both companies expect that the AbuDhabi22 bid will greatly exceed any bids made via ordinary exchange channels. With a bid offering at a stable price, the TOB method was chosen for its strategic worth. The MINDOL business vision for 2019 sets a target for its cryptocurrency, from among the more than 2,000 types of cryptocurrencies currently available, to have a top-30 market capitalization. As a business that focuses on "the fusion of subculture and blockchain," they will develop an online game that ta